TT Virus SCIENCE WATCH. PETER A. L. BONIS UpToDate, Inc. Wellesley, Massachusetts, and New England Medical Center, Boston, Massachusetts.
|
|
- Jennifer Burns
- 6 years ago
- Views:
Transcription
1 SCIENCE WATCH J Am Soc Nephrol 10: , 1999 TT Virus PETER A. L. BONIS UpToDate, Inc. Wellesley, Massachusetts, and New England Medical Center, Boston, Massachusetts. Abstract. TT virus (TTV) is a newly described DNA virus that was first detected in the blood of three patients with elevated serum aminotransferases following transfusion who tested negatively for all known hepatitis viruses. The virus has been found worldwide with a high prevalence in the general population. However, accumulating evidence suggests that the virus is not a significant cause of acute or chronic liver disease. No other disease associations with infection have been described. After the discovery of the hepatitis A and B viruses in the 1960s and 1970s, it became apparent that an unidentified agent was responsible for hepatitis in a number of patients suspected of having acute or chronic viral hepatitis. The unknown pathogen was referred to as non-a non-b hepatitis until the hepatitis C virus was identified in 1989 and was found to account for hepatitis in the majority of these patients (1). However, in approximately 5% of patients with liver disease, no cause can be identified (2). It has long been suspected that additional hepatotropic viruses will be discovered to account for some of these cases, especially since approximately half of these patients have a history of blood transfusion (2). The hepatitis G virus, identified in 1996, has proven to be an unlikely candidate since an association with hepatitis or any other disease has not been consistently demonstrated (3). A novel virus associated with posttransfusion hepatitis was identified in 1997 in three patients from Japan who developed elevated serum aminotransferase concentrations following transfusion and tested negatively for all known hepatitis viruses (4). The virus (referred to as TT virus for the initials of the patient in whom it was isolated or transfusion transmitted virus [TTV]) exhibited hepatotropism, and its titers correlated with elevation in serum aminotransferase concentrations suggesting that it was a true hepatitis virus. Accumulating data have demonstrated a high prevalence of the virus in the general population, demonstrating that it is capable of producing chronic infection. TTV DNA has been detected in approximately 2% of blood donors in the United Kingdom, 1 to 10% in the United States (5,6), 12 to 40% in Japan (7 9), 14% in Korea (10), 13% in Germany (11), 62% in Brazil (12), 11% in Spain (13), and 10% in Columbia (14). TTV may be acquired early in life, particularly in countries with a high prevalence of infection in the general population. A series from Japan found that 5% of 197 children seen in a general pediatric center had TTV DNA detectable in serum Correspondence to Dr. Peter A. L. Bonis, UpToDate, Inc., 34 Washington Street, Wellesley, MA Phone: , extension 288; Fax: ; Pbonis@UpToDateInc.com / Journal of the American Society of Nephrology Copyright 1999 by the American Society of Nephrology (15). In another report from the Democratic Republic of Congo, TTV was found in 61 of 105 women (58%) attending an antenatal clinic and 36 of 68 (54%) of infants (16). The virus can be detected in the stool and bile of infected patients, suggesting that it may be transmitted enterally (17,18). A high prevalence of infection has been found in patients with parenteral exposure to blood. TTV DNA was detected in 44% of patients with hemophilia in the United Kingdom (19), and up to 75% in Japan (20,21). A report from China found a prevalence of 22% among those with a history of intravenous drug use. (22). TTV was present in 84% of Italian patients with transfusion-dependent beta thalassemia (23). Despite its high prevalence, an association between TTV infection and acute or chronic hepatitis or other diseases has not been consistently observed. Furthermore, the initial observation of hepatotropism has not been confirmed (24), and injection of the virus into chimpanzees, while capable of causing infection, did not produce clinical illness (25). Phylogenetic Analysis TTV is an unenveloped, single-stranded DNA virus that has similarities to the Circoviridae viruses known to infect plants and vertebrates (25). However, it has been classified as a member of a new family of viruses, the Circinoviridae, based on its distinct biophysical and molecular characteristics. Phylogenetic analysis of isolates pooled from worldwide sources has demonstrated at least three genotypes and multiple subtypes (designated 1a, 1b, 1c, 2a f,and 3); the different genotypes do not appear to be geographically clustered (21,25 33). A possible fourth genotype has been reported in Columbia, Belgium, and Korea (10,14,31). The majority of patients are infected by genotype 1. However, coinfection with multiple genotypes is common, particularly in patients who have had multiple exposures to blood products (28). No differences in clinical outcomes among the various genotypes have been observed (32). Natural History The natural history of TTV infection has not yet been defined. The presence of TTV infection has been based on the detection of its DNA in serum or tissue samples. Thus, little is known about the immune response to the virus or the frequency
2 J Am Soc Nephrol 10: , 1999 TT Virus 1829 with which an acute exposure leads to viral clearance. Antibodies against TTV have been detected and will help to clarify these issues (34). Preliminary reports in patients who have been followed longitudinally have suggested a low rate of viral clearance. As an example, TTV DNA remained persistently detectable for 3 yr in a cohort of 19 patients (35). In another report, 97% of 93 patients who were followed for 3 yr remained viremic (23). A third series suggested an annual clearance rate of approximately 7% (36). However, many of the patients in these series had exposure to blood products. Thus, the extent to which the persistence of TTV DNA represents chronic infection by a single genotype or the acquisition of new genotypes remains uncertain. Clinical Significance The presence of TTV has been sought in a number of clinical settings, which will be summarized below. However, much of the information has been reported only in preliminary form. Thus, an understanding of its possible clinical significance is evolving. Hemodialysis A number of series have found a high prevalence of TTV infection among patients undergoing hemodialysis particularly in Japan (30,36 39). As an example, in a series of 115 patients from Japan, TTV DNA was detected in 51%, compared to 13% in healthy blood donors (37). Serum alanine aminotransferase concentrations were similar between those with and without TTV DNA. The high prevalence among Japanese patients on hemodialysis may reflect the relatively high prevalence in the general population. A much lower prevalence of infection was found in a series from France in which TTV DNA was detected in only two of 84 (2%) patients on hemodialysis (40). In addition, the prevalence of TTV infection may depend on the number of years that patients have been receiving hemodialysis (38). This was illustrated in a series that included 50 Japanese patients with hepatitis C who were followed for 48 mo while on hemodialysis (36). TTV DNA was present in 48% at the start of the study. A history of blood transfusions was similar among those with and without infection. During follow-up, four patients developed new infection; the estimated annual infection rate was 4%. However, in other reports, the presence of TTV was unrelated to the number of years of dialysis (39). Renal Transplantation A study from Japan found that the acquisition of TTV infection after renal transplantation was common but of uncertain clinical significance (39). New infection after transplantation was detected in nine of 25 (36%) patients. Three of these patients demonstrated an elevated serum alanine aminotransferase concentration, which subsequently normalized in two. An adverse effect on graft survival has not been reported. Association with Acute Liver Disease TTV DNA has been detected in patients with acute hepatitis of otherwise unknown etiology (7,8,41 44), but a correlation of TTV titers and serum aminotransferase concentrations has been inconsistent. Thus, it remains unclear whether the virus was the cause of the liver disease or was an incidental finding. Some reports have suggested that the virus may be associated with acute hepatitis in a subset of patients. This was illustrated in a study that included 25 Japanese patients undergoing bone marrow transplantation of whom 60% were positive for TTV DNA after transplantation (45). No significant difference was observed in the incidence of veno-occlusive disease, graft versus host disease, or biochemical evidence of liver dysfunction based on TTV status. However, in one patient serial semiquantification of TTV DNA in serum closely correlated with the serum alanine aminotransferase levels. A liver biopsy specimen was consistent with acute hepatitis, and TTV DNA was detectable in liver tissue by PCR. Association with Chronic Liver Disease of Unknown Etiology The presence of TTV DNA does not appear to be associated with biochemical or histologic evidence of liver injury of unknown cause in most reports (24,40,46 48). In one study, for example, no significant difference in the prevalence of TTV DNA was found between 99 blood donors in the United States who had an elevated serum alanine aminotransferase compared with 46 control subjects (46). Similar findings were found in Spain (13). In a report from Japan, the prevalence of TTV DNA was similar between 50 patients with chronic liver disease of unknown etiology and 106 volunteer blood donors (47). In contrast to these reports, another series from Japan supported a potential role for TTV in the development of chronic liver disease (42). The prevalence of TTV DNA was significantly higher among 57 patients with chronic liver disease of unknown etiology compared to 96 patients known to have chronic liver disease due to hepatitis C (47% versus 18%). Similarly, in a series from the United States, the prevalence of TTV was much higher among 33 patients with cryptogenic cirrhosis compared with 100 healthy blood donors (15% versus 1%) (5). Association with Known Forms of Chronic Liver Disease Several reports have demonstrated an increased prevalence of TTV DNA in patients with a variety of chronic liver diseases compared to control populations (5,20,21,49 51). As an example, in one series from the United States, TTV was present in 27% of patients with fulminant hepatic failure and 18% of cirrhotic patients with a history of blood transfusion compared to 1% in healthy blood donors (5). However, in most reports TTV does not appear to contribute to the liver injury. In a study from Japan, for example, TTV DNA was not more common among hemophiliacs with an elevated alanine aminotransferase who were infected by hepatitis C virus compared to hepatitis C
3 1830 Journal of the American Society of Nephrology J Am Soc Nephrol 10: , 1999 virus-negative control subjects, suggesting that the liver injury was due to hepatitis C virus alone (21). In another report from the United Kingdom, the prevalence of TTV DNA among patients with chronic liver disease was similar to healthy control subjects (52). No significant difference was noted in the rate of TTV DNA among various forms of liver disease. The majority of TTV-positive patients had no biochemical or histologic evidence of significant liver disease. Thus, the increased prevalence of TTV among patients with various forms of liver disease suggests shared risk factors with TTV infection. Similar results have been found in other centers, which have also not detected a correlation between TTV status and the severity of liver disease (9,19,35,53,54) or outcome in patients undergoing treatment of hepatitis C virus with interferon (9,36,48,55). Interferon treatment has been associated with clearance of TTV infection. TTV DNA has been sought in a number of other settings related to liver disease. It does not appear to serve as a trigger for autoimmune hepatitis (56,57). No association between TTV DNA and cryoglobulinemia was found in a single report (58). Liver Transplantation TTV is frequently acquired after liver transplantation presumably because of the multiple transfusions that are often required during the procedure. In one report from the United States, for example, TTV DNA was found after transplantation in up to 44% of those who were initially negative for the virus before the procedure (59). Despite its high prevalence, its significance in the transplant setting is uncertain. In one report, patients who were TTVpositive after transplantation were significantly more likely to have idiopathic hepatitis on protocol liver biopsies at 12 mo (60). However, in other series TTV did not appear to have any association with clinical or histologic evidence of hepatitis (48,61). Conclusion An understanding of the biology and clinical significance of TTV is evolving. Increasing evidence suggests that it is not a significant cause of liver disease, although it may be capable of inducing hepatitis in a subset of patients. The continued search for TTV in non-liver-related clinical settings will help to determine whether the virus contributes to other human diseases. References 1. Alter M: Epidemiology of hepatitis C. Hepatology 26: 62S 65S, Kodali V, Gordon S, Silverman A, McCray D: Cryptogenic liver disease in the United States: Further evidence for non-a, non-b, and non-c hepatitis. Am J Gastroenterol 89: , Miyakawa Y, Mayumi M: Hepatitis G virus: A true hepatitis virus or an accidental tourist? N Engl J Med 336: , Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92 97, Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R: TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 28: , Desai S, Muerhoff S, Leary T, Erker J, Simons J, Chalmers M, Birkenmeyer L, Pilot-Matias T, Mushawar I: Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis 179: , Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM: Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352: , Okamoto H, Nishizawa T, Kato N: Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 10: 1, Kato T, Mizokami M, Orito E, Ohno T, Nakano T, Tanaka Y, Kato H, Mukaide M, Ueda R: High prevalence of TT virus infection among the Japanese hepatocellular carcinoma patients and blood donors [Abstract]. Hepatology 28: A519, Nakano T, Park YM, Mizokami M, Choi JY, Orito E, Ohno T, Kato T, Kondo Y, Tanaka Y, Kato H, Kim BS: TT virus infection among blood donors and patients with non-b, non-c liver diseases in Korea. J Hepatol 30: , Viazov S, Ross RS, Varenholz C, Lange R, Holtmann M, Niel C, Roggendorf M: Lack of evidence for an association between TTV infection and severe liver disease. J Clin Virol 11: , Niel C, de Oliveira JM, Ross RS, Gomes SA, Roggendorf M, Viazov S: High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 57: , Gimenez-Barcons M, Ampurdanes S, Soler M, Forn X, Soguero C, Guilera M, Sanchez A, Sanchez-Tapisa J, Rodes J, Saiz J: Prevalence of TT virus infection among patients with liver diseases [Abstract]. Hepatology 28: A823, Tanaka Y, Mizokami M, Orito E, Nakano T, Kato T, Ding X, Ohno T, Ueda R, Sonoda S, Tajima K, Miura T, Hayami M: A new genotype of TT virus (TTV) infection among Colombian native Indians. J Med Virol 57: , Goto K, Sugiyama K, Terabe K, Mizutani F, Wada Y: Detection rates of TT virus among children who visited a general hospital in Japan. J Med Virol 57: , Davidson F, MacDonald D, Mokili J, Prescott L, Graham S, Simmonds P: Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 179: , Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M: Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-a-g hepatitis. J Med Virol 56: , Ukita M, Okamoto H, Kato N, Miyakawa Y, Mayumi M: Excretion into bile of a novel unenveloped DNA virus (TT virus) associated with acute and chronic non-a-g hepatitis. J Infect Dis 179: , Irving W, Ball J, Berridge S, Curran R, Grabowska A, Jameson C, Thomson B, Rynder S: Chronic infection with TT virus: Frequency, effect on chronic HCV infection and virus evolutions [Abstract]. Hepatology 28: A800, Fukuda Y, Nakano I, Katano Y, Toyoda H, Ebata M, Nagano K, Morita K, Yokazaki S, Takeuchi M, Hayashi K, Takamatsu J, Hayakawa T: TT virus infection in Japanese hemophilia patients [Abstract]. Hepatology 28: A516, 1998
4 J Am Soc Nephrol 10: , 1999 TT Virus Takayama S, Miura T, Matsuo S, Taki M, Sugii S: Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs. Br J Haematol 104: , Cao K, Mizokami M, Orito E, Ding X, Ge X, Huang G, Ueda R: TT virus infection among intravenous drug users in southwest China [Abstract]. Hepatology 28: A517, Prati D, Lin YH, De Mattei C, Liu JK, Farma E, Ramaswamy L, Zanella A, Lee H, Rebulla P, Allain JP, Sirchia G, Chen B: A prospective study on TT virus infection in transfusion-dependent patients with beta-thalassemia. Blood 93: , Petrova E, Thomas M, Williams R, Naoumov N: A study on a novel DNA virus (TTV) in liver disease patients and its causative role for hepatitis [Abstract]. Hepatology 28: A816, Mushahwar IK, Erker JC, Muerhoff AS, Leary TP, Simons JN, Birkenmeyer LG, Chalmers ML, Pilot-Matias TJ, Dexai SM: Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans. Proc Natl Acad Sci USA 96: , Schreier E, Hoehne M, Berg T, Muller A, Wiedenmann B, Neuhaus P, Hopf U: Sequence variation and phylogenetic analysis of a novel DNA virus (TTV) in German patients [Abstract]. Hepatology 38: A511, Okamoto H, Kato N, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M: Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-a to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells. J Med Virol 57: , Takayama S, Yamazaki S, Matsuo S, Sugii S: Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs. Biochem Biophys Res Commun 256: , Tanaka Y, Mizokami M, Orito E, Ohno T, Nakano T, Kato T, Kondo Y, Mukaide M, Ueda R: TT virus (TTV) genotyping assay based on restriction fragment length polymorphism [Abstract]. Hepatology 28: 4, Tanaka H, Ueda H, Doi R, Miyano M, Mimura K, Yukawa S: TT virus (TTV) in Japanese patients with liver disorders and on hemodialysis [Abstract]. Hepatology 28: A2258, Vreese K, Ducatteeuw A, Depla E, Priem S, Leroux-Roels G, De Groote G, Maertens G: Detection of new TTV genotypes 2c, 2d, 3, and 4 in Belgian patients with hepatitis of unknown etiology [Abstract]. Hepatology 28: A526, Orito E, Mizokami M, Ohno T, Nakano T, Kato T, Kondo Y, Tanaka Y, Kato H, Ueda R, Gojobori T: Molecular phylogenetic analysis of TT virus (TTV) genotype [Abstract]. Hepatology 28: A973, Viazov S, Ross RS, Niel C, de Oliveira JM, Varenholz C, Da Villa G, Roggendorf M: Sequence variability in the putative coding region of TT virus: Evidence for two rather than several major types. J Gen Virol 79: , Pinho JR, Takahashi DA, Fava AL, Goncales NS, Carrilho FJ, Stucchi RS, Goncales Junior FL, Da Silva LC, Soares MC, Bensabath G, Buck GA, Meyers GA, Bernardini AP: Transfusion-transmitted virus (TTV) in Brazil. Preliminary report. Rev Inst Med Trop Sao Paulo 40: , Hada T, Cheng J, Fukui K, Ohno M, Ohkawa T, Yokoyama Y, Imanishi H, Hara N, Iijima H, Shimomura S, Yamamoto T, Amuro Y, Higashino K: Detection of TTV DNA in sera of patients with chronic liver diseases and interferon efficacy [Abstract]. Hepatology 28: A815, Yuki N, Kato M, Masuzawa M, Ishida H, Inoue T, Matsushita Y, Tabata T, Kishimoto H, Yamamoto K, Kaneko A, Michida T, Iyoda K, Sugiyasu Y, Fujii E, Kurosawa K, Ideda M, Sasaki Y, Kasahara A, Hayashi N, Hori M: Clinical relevance of chronic infection with TT virus, a novel hepatitis associated agent in patients on maintenance haemodialysis [Abstract]. Hepatology 28: A513, Utsonomiya S, Yoshioka K, Wakita T, Takagi KM, Yano M, Watanabe K, Kobayashi M, Watanabe K, Kishimoto H, Kakumu S: TT virus infection in hemodialysis patients [Abstract]. Hepatology 28: A512, Sawada T, Ishikawa T, Okumura A, Tagaya T, Yamada H, Fukatsu A, Kakumu S: High prevalence of hepatitis virus infection in hemodialysis patients: Epidemiology and clinical implications [Abstract]. Hepatology 28: A820, Michitaka K, Koriike N, Matsubara H, Kojima N, Onji M, Toshino A, Oka A, Ohoka H, Yokoyama M: TT virus infection among renal transplant recipients [Abstract]. Hepatology 28: A2278, Halfon P, Bourliere M, Feryn JM, Khiri H, Chanas M, Salvadori JM, Ouzan D: Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: Hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients. J Hepatol 30: 552, Tuveri R, Jaffredo F, Pol S, Lunel F, Marcellin P, Delangeau J, Brechot C, Thiers V: Prevalence of TTV viral DNA sequences in patients with acute and chronic liver disease [Abstract]. Hepatology 28: A2259, Ikeda H, Takasu M, Inoue K, Okamoto H, Miyakawa Y, Mayumi M: Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. J Hepatol 30: , Cleavinger P, Zein N, Freese D, Perrault J, Persing D, Charlton M: Detection of a novel viral agent linked with post transfusion hepatitis (TT virus) in pediatric patients with fulminant hepatic failure [Abstract]. Hepatology 28: A2266, YouLuTuz Y, Matsui A, Mochida S, Fujiwara K: TT virus infection in patients with fulminant hepatitis [Abstract]. Hepatology 28: A2265, Kanda Y, Tnaka Y, Kami M, Saito T, Asai T, Izutsu K, Yuji K, Ogawa S, Honda H, Mitani K, Chiba S, Yazaki Y, Hirai H: TT virus in bone marrow transplant recipients. Blood 93: , Zein N, Charlton M, Li H, Cleavinger P, Sievers C, Persing D: Prevalence of TT virus in sera obtained from blood donors with elevated ALT in the absence of known hepatitis markers [Abstract]. Hepatology 28: A163, Enomoto M, Nishiguchi S, Tanaka M, Minamitani S, Fukuda K, Tamori A, Habu D, Tanaka T, Takeda T, Shiomi S, Seki S, Yano Y, Otani S, Kuroki T: Prevalence of TT virus in patients with chronic liver disease of unknown etiology and volunteer blood donors: Nucleotide sequences of TT virus genome and evidence for distinct genotypes [Abstract]. Hepatology 28: A514, Berg T, Schreier E, Hohne, Bechstein W, Leder K, Wiedenmann W, Neuhaus P, Hopf U: Frequency of TT virus infections in cryptogenic cirrhosis before and after liver transplantation in patients with chronic hepatitis C treated with interferon alfa [Abstract]. Hepatology 28: A974, Ding X, Mizokami M, Kang L, Orito E, Cao K, Tanaka Y, Ueda R, Sasaki M: TT virus and GBV-C among patients with liver diseases and general population in Shanghai China [Abstract]. Hepatology 28: A2262, Tanaka H, Okamoto H, Luengrojanakul P, Chainuvati T, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M: Infection with an unen-
5 1832 Journal of the American Society of Nephrology J Am Soc Nephrol 10: , 1999 veloped DNA virus (TTV) associated with posttransfusion non-a to G hepatitis in hepatitis patients and healthy blood donors in Thailand. J Med Virol 56: , Chayama K, Kobayashi M, Tsubota A, Arase Y, Suzuki Y, Saitoh S, Murashima N, Ikeda K, Okamoto K, Hashimoto M, Matsuda M, Koike H, Kumada H: Susceptibility of TT virus to interferon therapy. J Gen Virol 80: , Naoumov NV, Petrova EP, Thomas MG, Williams R: Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 352: , Umemura T, Tanaka E, Orii K, Imai H, Yoshizawa K, Ota M, Kiyosawa K: TT virus infection in high and non endemicity areas for hepatitis C [Abstract]. Hepatology 28: A812, Zein N, Charlton M, Arslan M, Gross B, Poterucha J, Persing D: The role of TT virus coinfection in the progression of hepatitis C associated liver disease in patients with chronic hepatitis C [Abstract]. Hepatology 28: A523, Hagiwara H, Hayashi N, Mita E, Oshita M, Kobayashi I, Iio S, Hiramatsu N, Sasaki Y, Kasahara A, Kakinuma K, Yamauchi T, Fusamoto H: Influence of TTV infection on the clinical features and the response to interferon therapy in patients with chronic hepatitis C [Abstract]. Hepatology 28: A828, Enomoto M, Nishiguchi S, Obata N, Tanaka M, Minamitani S, Fukuda K, Tamori A, Habu D, Tanaka T, Takeda T, Shiomi S, Seki S, Yano Y, Toani S, Kuroki T: Role of GB virus C or TT virus as a trigger of autoimmune hepatitis in Japan [Abstract]. Hepatology 28: A220, Kurokohchi K, Itoh A, Arima K, Nishioka M: Detection of a novel DNA virus (TTV) and its association with the development of autoimmune hepatitis (AIH) [Abstract]. Hepatology 28: A1955, Cacoub P, Halfon P, Mussett L: Transfusion-transmitted virus and mixed cryoglobulinemia [Letter]. Ann Intern Med 130: , Fried M, Khudyakov Y, Cong M, Nichols B, Smallwood G, Heffron T, Stieber A, Gordon R, Fields H: Presence of a new DNA virus (TTV) in sera from patients undergoing liver transplantation for chronic hepatitis C and nonviral liver disease [Abstract]. Hepatology 28: A400, Adjei P, Cleavinger P, Persing D, Zein N, Poterucha J, Krom R, Wiesner R, Charlton M: Prevalence of TT virus infection in liver transplant recipients and impact on posttransplant histology [Abstract]. Hepatology 28: A904, Schroeder B, Gane E, Munn S, Wesley A, Woodfield G, Croxson M: Detection and characterization of TTV in New Zealand liver transplant recipients [Abstract]. Hepatology 28: A2268, 1998
Prevalence and Phylogenetic Analysis of TT Virus DNA in Western India
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2000, p. 845 849 Vol. 7, No. 5 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Prevalence and Phylogenetic
More informationPresence of TT virus infection in chronic hepatitis patients from a hospital in New Delhi, India
Indian J Med Res 122, July 2005, pp 29-33 Presence of TT virus infection in chronic hepatitis patients from a hospital in New Delhi, India Saket Chattopadhyay, B.C. Das*, R.K. Gupta & P. Kar PCR-Hepatitis
More informationTransfusion-transmitted virus infection in HIV-1-seropositive patients
ORIGINAL ARTICLE Transfusion-transmitted virus infection in HIV-1-seropositive patients M. Debiaggi 1, F. Zara 2, P. Sacchi 2, R. Bruno 2, M. Mazzucco 3, R. Poma 3, F. Raffaldi 5, L. Gerace 5, M. Perini
More informationORIGINAL ARTICLE. Departments of 1 Internal Medicine, 2 Virology and 3 Blood Bank, Gülhane School of Medicine, Ankara, Turkey
ORIGINAL ARTICLE Transfusion-transmitted virus prevalence in subjects at high risk of sexually transmitted infection in Turkey M. Yazici 1,M.R.Cömert 1, R. Mas 1, C. Guney 2, E. Cinar 3 and I. H. Kocar
More informationA Case-Control Study on a Novel DNA Virus (TT Virus) Infection and Hepatocellular Carcinoma
A Case-Control Study on a Novel DNA Virus (TT Virus) Infection and Hepatocellular Carcinoma ALESSANDRO TAGGER, 1 FRANCESCO DONATO, 2 MARIA LISA RIBERO, 3 GIORGIO BINELLI, 4 UMBERTO GELATTI, 2 GIUSEPPE
More informationTT Virus Infection in French Hemodialysis Patients: Study of Prevalence and Risk Factors
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2538 2542 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. TT Virus Infection in French Hemodialysis
More informationQuasispecies of TT Virus (TTV) with Sequence Divergence in Hypervariable Regions of the Capsid Protein in Chronic TTV Infection
JOURNAL OF VIROLOGY, Nov. 1999, p. 9604 9608 Vol. 73, No. 11 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Quasispecies of TT Virus (TTV) with Sequence Divergence
More informationORIGINAL ARTICLE. Clin Microbiol Infect 2003; 9: 39 44
ORIGINAL ARTICLE Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-hodgkin lymphoma P. Cacoub 1,
More informationTransfusion-Associated TT Virus Infection and Its Relationship to Liver Disease
Transfusion-Associated TT Virus Infection and Its Relationship to Liver Disease AKIHIRO MATSUMOTO, 1 ANTHONY E. T. YEO, 1 J. WAI KUO SHIH, 1 EIJI TANAKA, 2 KENDO KIYOSAWA, 2 AND HARVEY J. ALTER 1 TT virus
More informationChanges in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy
MAJOR ARTICLE Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy Hidenori Toyoda, 1 Takashi Kumada, 1 Seiki
More informationWeak Association between SEN Virus Viremia and Liver Disease
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2002, p. 3140 3145 Vol. 40, No. 9 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.9.3140 3145.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationDetection of IgA-class anti-hev antibody
Detection of IgA-class anti-hev antibody Hiroaki OKAMOTO E IgA-HE IgA HEV E HEV E E E 10 E 1997 E E 1, 2 2001 E 3 HEV 4 1979 HEV 5 A B C A B C E 6, 7 E HEV E 8 11 2003 8 19 http:www.mhlw. go.jphoudou200308h0819-2.html
More informationHCV HIV +*+ Human immunodeficiency virus HIV hepatitis C virus HCV HIV HCV HCV HIV HIV
,**- The Japanese Society for AIDS Research The Journal of AIDS Research +0 HIV HCV + + + + + + + + +, +, :HCV HIV HAART / : +*+ +*0,**- Human immunodeficiency virus HIV hepatitis C virus HCV HIV,* HCV
More informationPast and Present Hepatitis G Virus Infections in Areas Where Hepatitis C is Highly Endemic and Those Where It Is Not Endemic
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 1998, p. 110 114 Vol. 36, No. 1 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Past and Present Hepatitis G Virus Infections in Areas Where
More informationNo Effect of Transfusion Transmitted Virus Viremia on the Distribution and Activation of Peripheral Lymphocytes in Hemodialyzed Patients
Short Communication Nephron 2002;92:933 937 DOI: 10.1159/000065449 Accepted: May 1, 2002 No Effect of Transfusion Transmitted Virus Viremia on the Distribution and Activation of Peripheral Lymphocytes
More informationTorque Teno Virus (TTV) Infection In Egyptian Patients with Chronic Liver Disease and Hepatocellular Carcinoma
Torque Teno Virus (TTV) Infection In Egyptian Patients with Chronic Liver Disease and Hepatocellular Carcinoma Maisa Omar 1, Nevine Fam 1, Samah Saad El-Din 1, Mahmoud Romeih 2, Hanem Mohamed 2, Moatez
More informationTT Virus infection in the elderly
JOURNAL OF PREVENTIVE MEDICINE AND HYGIENE 1999; 40: 89-92 ORIGINAL ARTICLE TT Virus infection in the elderly A. FLOREANI, V. BALDO 1, S. BUORO 2, L. MAZZARIOL 3, M. FAVARATO 3, R. TRIVELLO 2 AND COLLABORATIVE
More informationMolecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients a
ORIGINAL ARTICLE Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients a Maha A. Al-Mozaini,* Mohammed N. Al-Ahdal,* George Kessie,* b Damian M. Dela
More information: TP6.3 g dl, Alb4.3 g dl, GOT17 IU l, GPT26 IU l,
5 Vol. 34, pp. 5 23, 2006 C IFN 0 2 : 8 4 20 63 986 990 C 993 S7 C A F2 IFN IFNa2a 9MIU 24W HCV-RNA 995 2 F HCV-RNA IFN 0 2004 5 S8 20 mm CT SPIO-MRI 6 TP6.3 g dl, Alb4.3 g dl, GOT7 IU l, GPT26 IU l, g-gtp40
More informationRole of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation
BRIEF REPORT Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation Man-Fung Yuen, 1 Erwin Sablon, 2 Danny Ka-Ho Wong, 1 He-Jun Yuan, 1 Benjamin Chun-Yu Wong, 1 Annie On-On Chan, 1 and
More informationEffects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
Yamasaki et al. BMC Gastroenterology 212, 12:139 RESEARCH ARTICLE Open Access Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients Kazumi Yamasaki 1,6*, Mayumi Tomohiro 2, Yumiko
More informationHEV, TTV and GBV-C/HGV markers in patients with acute viral hepatitis
Brazilian Journal of Medical and Biological Research (2005) 38: 767-775 Viral markers in patients with acute hepatitis ISSN 0100-879X 767 HEV, TTV and GBV-C/HGV markers in patients with acute viral hepatitis
More informationTT VIRUS INFECTION IN ACUTE NON-A TO E HEPATITIS IN NORTHERN THAILAND
TT VIRUS INFECTION IN ACUTE NON-A TO E HEPATITIS IN NORTHERN THAILAND Timothy P Endy', Sumitda Narupiti', Khin Saw Aye Myint', Saroj Suntayakorn2, Robert A Kuschner3 and David W Vaughn3 'Department of
More informationHBV Core and Core-Related Antigen Quantitation in Chinese Patients with. Chronic Hepatitis B Genotype B and C Virus Infection
Title page HBV Core and Core-Related Antigen Quantitation in Chinese Patients with Chronic Hepatitis B Genotype B and C Virus Infection Short Title: Quantitation of HBc and HBcrAg in Chinese patients Akinori
More informationC genotype 1 HCV HIV. B genotype A
C genotype 1 IL-28B SNP ITPA SNP 3 HCV HIV B B genotype A 2013 A-0 Nishida N, Sawai H, Kashiwase K, Minami M, Sugiyama M, Seto WK, Yuen MF, Posuwan N, Poovorawan Y, Ahn SH, Han KH, Matsuura K, Tanaka Y,
More informationReview Article. Newer Hepatitis Viruses
INDIAN PEDIATRICS VOLUME 34-OCTOBER 1997 Review Article Newer Hepatitis Viruses K. Rajeshwari For nearly two decades the only addition to the hepatitis alphabet was the delta agent (hepatitis D virus,
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationE E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV
7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan
More informationHealthy Liver Cirrhosis
Gioacchino Angarano Clinica delle Malattie Infettive Università degli Studi di Foggia Healthy Liver Cirrhosis Storia naturale dell epatite HCVcorrelata in assenza di terapia Paestum 13-15 Maggio 24 The
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationReceived 30 May 2004/Returned for modification 6 August 2004/Accepted 12 August 2004
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2004, p. 5036 5040 Vol. 42, No. 11 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.11.5036 5040.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationPapers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA
J Clin Pathol 1999;52:807 811 807 Papers Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical College Hospital, No 100, Shih-Chuan 1st Rd, Kaohsiung, Taiwan, Republic of China M-L
More informationEpidemiology of HCV infection among HD pts in Iran and prevention strategies
Epidemiology of HCV infection among HD pts in Iran and prevention strategies B. Einollahi Professor of Internal Medicine/Nephrology Division Baqiyatallah University of Medical Sciences 4th International
More informationORIGINAL INVESTIGATION. Age-Related Response to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection
ORIGINAL INVESTIGATION Age-Related to Interferon Alfa Treatment in Women vs Men With Chronic Hepatitis C Virus Infection Jun Hayashi, MD, PhD; Yasuhiro Kishihara, MD; Kumiko Ueno, MD; Kouzaburo Yamaji,
More informationPrevalence of hepatitis G virus in liver disease
HEPATOLOGY in liver disease Hitoshi Takagi MD PhD, Satoru Kakizaki MD PhD, Ken Satoh MD PhD, Mitsuo Toyoda MD, Norio Horiguchi MD, Hisashi Takayama MD PhD, Daisuke Kanda MD PhD, Hiroaki Nakajima MD, Takeshi
More informationInterferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1
Title Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1 Author(s) Hui, CK; Yuen, MF; Sablon, E; Chan, AOO; Wong, BCY; Lai, CL Citation Journal Of Infectious
More informationLiver Biopsy in Chronic Viral Hepatitis (B And C) and Autoimmune Hepatitis Referred to Shahid Sadoughi Hospital Yazd, Iran
Original Article Liver Biopsy in Chronic Viral Hepatitis (B And C) and Autoimmune Hepatitis Referred to Shahid Sadoughi Hospital Yazd, Iran * Shokouh Taghipour Zahir,** Jamshid Ayatollahi From Department
More informationon October 4, 2018 by guest
JCM Accepts, published online ahead of print on 3 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.01249-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Title: Performance of
More informationHepatitis G Virus Infection Before and After Liver Transplantation
Hepatitis G Virus Infection Before and After Liver Transplantation Jay H. Hoofnagle,* Manuel Lombardero, Yuling Wei, James Everhart,* Russell Wiesner, Rowen Zetterman, Andersen J. Yun,6 Limei Yang,6 and
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationHigh Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B
MAJOR ARTICLE High Levels of Hepatitis B Virus After the Onset of Disease Lead to Chronic Infection in Patients With Acute Hepatitis B Hiroshi Yotsuyanagi, 1,a Kiyoaki Ito, 2,5,a Norie Yamada, 1,3,4 Hideaki
More informationWhat are the risk-factors with an impact on fatality rate in fulminant hepatitis A?
What are the risk-factors with an impact on fatality rate in fulminant hepatitis A? Daniel Shouval Liver Unit Hadassah-Hebrew University Jerusalem, Israel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
More informationMulticentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status
Journal of Viral Hepatitis, 2006, 13, 329 335 doi:10.1111/j.1365-2893.2005.00692.x Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen
More information-HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual
2013: HCV Genome -HCV genome is about 9400 nucleotides long, it is ssrna and positive sense -the 10 viral proteins are first made as a large polyprotein -individual proteins are released from polyprotein
More informationSEN Virus Infection and Its Relationship to Transfusion-Associated Hepatitis
SEN Virus Infection and Its Relationship to Transfusion-Associated Hepatitis TAKEJI UMEMURA, 1 ANTHONY E. T. YEO, 1 ALESSANDRA SOTTINI, 2 DANIELE MORATTO, 2 YASUHITO TANAKA, 1 RICHARD Y.-H. WANG, 1 J.
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationThe Role of Hepatitis Virus and Alcohol in Chronic Liver Disease
5 2 1999 ; 83 88 The Role of Hepatitis Virus and Alcohol in Chronic Liver Disease Sangok Kwon, M.D. and Soonkoo Baik, M.D. Department of Internal Medicine, Wonju College of Medicine, Yonsei University,
More informationGB virus Whepatitis G virusis it a novel human hepatitis virus?
REVIEW GB virus Whepatitis G virusis it a novel human hepatitis virus? Clin Microbiol Infect 1998; 4: 677-681 Galina Zhelexova Zhelexova and Ludmila Angelova Karaivanova, University Hospital St Ivan Rilski,
More informationHepatitis E Virus Infection. Disclosures
Hepatitis E Virus Infection Simona Rossi, MD Associate Chair, Division of Hepatology Einstein Medical Center Philadelphia Consultant for BMS Speaker for Gilead Disclosures I have no conflicts to report
More informationDetection in chimpanzees of a novel flavivirus related to GB virus-c/hepatitis G virus
Journal of General Virology (1998), 79, 1871 1877. Printed in Great Britain...... Detection in chimpanzees of a novel flavivirus related to GB virus-c/hepatitis G virus N. J. Adams, 1 L. E. Prescott, 1
More information1Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Campus Universitário, Londrina, CEP , PR, Brazil.
CLINICAL STUDY Molecular Investigation of GB Virus C RNA in Hemodialysis and Thalassemics Patients from Brazil Prof. Dr. Maria Angelica Ehara Watanabe, Ph.D.*1, Cristiane Maria Milanezi2, Wilson Araújo
More informationEighty percent of hepatocellular carcinoma cases are caused by infection with hepatitis B virus
Chapter 1 Prevention Introduction Eighty percent of hepatocellular carcinoma cases are caused by infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). Cases of fatty liver and nonalcoholic
More informationReceived 18 March 1996/Returned for modification 11 June 1996/Accepted 10 September 1996
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1996, p. 2875 2880 Vol. 34, No. 12 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Differential Prevalence of Hepatitis C Virus Subtypes in
More informationJOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p Vol. 38, No. 2. Copyright 2000, American Society for Microbiology. All Rights Reserved.
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 662 668 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Prevalence of GB Virus C/Hepatitis G
More informationEvaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C
Evaluation of Interferon Treatment in Cirrhotic Patients with Hepatitis C Tatsuya IDE, Michio SATA, Hiroshi SUZUKI, Shiroh MURASHIMA, Ichiroh MIYAJIMA, Miki SHIRACHI and Kyuichi TANIKAWA The Second Department
More informationHepatitis A-E Viruses. Dr Nemes Zsuzsanna
Hepatitis A-E Viruses Dr Nemes Zsuzsanna Viral Hepatitis - Historical Perspectives Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D C Parenterally transmitted HGV, TTV, SEN, other
More informationIntron A Hepatitis B. Intron A (interferon alfa-2b) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.01 Subject: Intron A Hepatitis B Page: 1 of 7 Last Review Date: November 30, 2018 Intron A Hepatitis
More informationKEY WORDS: hemodialysis; HCV; diabetes; prognosis
Journal of Medical Virology 87:1558 1564 (2015) The Association of Hepatitis C Virus Infection With the Prognosis of Chronic Hemodialysis Patients: A Retrospective Study of 3,064 Patients Between 1999
More informationCorrelation between Vitamin D Receptor SNP ApaI and liver fibrosis in HCV patients from Thrace
Correlation between Vitamin D Receptor SNP ApaI and liver fibrosis in HCV patients from Thrace A. Beka 1, T. Mylopoulou 2, V. Papadopoulos 2, I. Karakasiliotis 2, P. Mavromara 1, K. Mimidis 2, S. Veletza
More informationSome HCV History 1970s: many cases reported called non-a, non-b hepatitis
Hepatitis C virus 1 Some HCV History 1970s: many cases reported called non-a, non-b hepatitis 1988: hepatitis C virus identified 1990: antibody screening tests available 1992: better tests to insure safety
More informationViral Hepatitis. Background
Viral Hepatitis Background Hepatitis or inflammation of the liver can be caused by infectious and noninfectious problems. Infectious etiologies include viruses, bacteria, fungi and parasites. Noninfectious
More informationHepatitis B virus genotypes in Southeast Brazil and its relationship with histological features
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(6): 758-789, September 2012 785 Hepatitis B virus genotypes in Southeast Brazil and its relationship with histological features Leticia Cancella Nabuco 1
More informationLymphoblastoid interferon alfa treatment in
152 Department of Paediatrics, University of Naples 'Federico II', Italy R Iorio P Pensati S Porzio I Fariello S Guida A Vegnente Correspondence and reprint requests to: Dr Raffaele Iorio, Dipartimento
More informationTTV As A Risk Factor In Hemodialysis Process
TTV As A Risk Factor In Hemodialysis Process By Iman Mohammed Ibrahim M.B., B. Ch. Faculty of Medicine, Ain Shams university1993 Master in clinical pathology, Faculty of Medicine, Ain Shams university1999
More informationHistory of Discoveries and Pathogenicity of TT Viruses
History of Discoveries and Pathogenicity of TT Viruses H. Okamoto Contents History of Discoveries... 2 Discovery of Original TT Virus... 2 Virological Characterization of TTV... 3 Discovery of Many TTV-Like
More informationHepatitis C virus infection in dialysis and renal transplantation
Kidney International, Vol. 51 (1997), pp. 981 999 PERSPECTIVES_IN CLINICAL NEPHROLOGY Hepatitis C virus infection in dialysis and renal transplantation Liver disease is an important cause of morbidity
More informationHepatitis E in South Africa. Tongai Maponga
Hepatitis E in South Africa Tongai Maponga 7th FIDSSA CONGRESS 2017 This is what usually comes to mind History of hepatitis E virus An ET-NANB hepatitis virus later named HEV was first suspected in 1980.
More informationAppendix Table A Frequency of end-stage liver disease in inception cohort. Reference Exposure followup Frequency ESLD (%) Seeff-1 PTH 24 23/568 (4%) 7
Published as supplied by the author Appendix Table A Frequency of end-stage liver disease in inception cohort studies Route of Years Reference Exposure followup Frequency ESLD (%) Locasciulli PTH 1 15
More informationUpdate on HIV-HCV Epidemiology and Natural History
Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,
More informationEpidemiological profiles of viral hepatitis in Italy Effects of migration
Epidemiological profiles of viral hepatitis in Italy Effects of migration Hepatitis A and E T. Santantonio UOC di Malattie Infettive Università degli Studi di Foggia Azienda Ospedaliero-Universitaria Ospedali
More informationPrevalence of GBV-C RNA in HIV infected individuals in Tehran, Iran
Iranian J Publ Health, Vol. 39, No.1, 2010, Iranian pp.22-27 J Publ Health, Vol. 39, No.1, 2010, pp.22-27 Original Article Prevalence of GBV-C RNA in HIV infected individuals in Tehran, Iran H Keyvani
More informationChanges in Clinical Characteristics of Non-B, Non-C Hepatocellular Carcinoma
293 Original Article St. Marianna Med J. Vol. 36, pp. 293301, 2008 Changes in Clinical Characteristics of Non-B, Non-C Hepatocellular Carcinoma Toshiya Ishii 1, Michihiro Suzuki 1, Nobuyuki Matsumoto 1,
More informationGB Virus C Prevalence in Blood Donors and High Risk Groups for Parenterally Transmitted Agents From Gauteng, South Africa
Journal of Medical Virology 55:103 108 (1998) GB Virus C Prevalence in Blood Donors and High Risk Groups for Parenterally Transmitted Agents From Gauteng, South Africa Alison Casteling, 1 * Ernie Song,
More informationThe Natural Course of Chronic Hepatitis C: A Comparison Between Patients With Genotypes 1 and 2 Hepatitis C Viruses
The Natural Course of Chronic Hepatitis C: A Comparison Between Patients With Genotypes 1 and 2 Hepatitis C Viruses MASANORI KOBAYASHI, EIJI TANAKA, TAKESHI SODEYAMA, AKIHIKO URUSHIHARA, AKIHIRO MATSUMOTO,
More informationThe ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses
The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection
More informationAssociation Between TT Virus Infection and Cirrhosis in Liver Transplant Patients
Hepat Mon. 2015 September; 15(9): e28370. Published online 2015 September 27. DOI: 10.5812/hepatmon.28370 Research Article Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients
More informationThe impact of the treatment of HCV in developing Hepatocellular Carcinoma
The impact of the treatment of HCV in developing Hepatocellular Carcinoma Paul Y Kwo, MD Professor of Medicine Medical Director, Liver Transplantation Gastroenterology/Hepatology Division Indiana University
More informationHepatitis-Associated Aplastic Anemia. Kazuko KUDO and Seiji KOJIMA Department of Pediatrics, Nagoya University Graduate School of Medicine
Hepatitis-Associated Aplastic Anemia Kazuko KUDO and Seiji KOJIMA Department of Pediatrics, Nagoya University Graduate School of Medicine Abstract We retrospectively analysed the clinical outcome of 85
More informationOpen Access Original Article
Open Access Original Article In-Vitro Transcription analysis of NS5A from HCV-3a circulating in Pakistani patients with chronic hepatitis C and their differential response to antiviral therapy Shameem
More informationThe Effect of Antiviral Therapy on Liver Fibrosis in CHC. Jidong Jia Beijing Friendship Hospital, Capital Medical University
The Effect of Antiviral Therapy on Liver Fibrosis in CHC Jidong Jia Beijing Friendship Hospital, Capital Medical University 2016-5-29 1 Disclosure Consultation for Abbvie, BMS, Gilead, MSD, Novartis and
More informationClinical Outcome of Hepatitis C as a Function of Mode of Transmission
Clinical Outcome of Hepatitis C as a Function of Mode of Transmission STUART C. GORDON, 1,2 NASSER BAYATI, 1 AND ANN L. SILVERMAN 1,2 Abbreviations: HCV, hepatitis C virus, ALT, alanine aminotransferase.
More informationIntron A Hepatitis C. Intron A (interferon alfa-2b) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.05 Subject: Intron A Hepatitis C Page: 1 of 5 Last Review Date: November 30, 2018 Intron A Hepatitis
More informationPERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases
PERINATAL HEPATIDES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) Pamela Palasanthiran Staff Specialist, Paediatric Infectious Diseases Viruses in July (ViJ), 2004 Overview Epidemiology Perinatal transmission
More informationDetection and significance of PD-1.3 SNP (rs ) and IL28B SNP (rs ) in patients with current or past hepatitis B virus (HBV) infection
Detection and significance of PD-1.3 SNP (rs11568821) and IL28B SNP (rs12979860) in patients with current or past hepatitis B virus (HBV) infection Asterios Saitis 1, Nikolaos K. Gatselis 1, Kalliopi Azariadi
More informationManagement of HBV in KidneyTransplanted Patients Dr.E.Nemati
Management of HBV in KidneyTransplanted Patients Dr.E.Nemati Hepatitis B virus (HBV) infection Hepatitis B virus (HBV) infection confers a significantly negative impact on the clinical outcomes of kidney
More informationClinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL
Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL The World Health Organisation recent initiatives on HBV infection Launching of the
More informationTransmission of HEV by plasmapheresis. Vincent Mallet, MD, PhD CHU Cochin, Université Paris Descartes, APHP, Inserm
Transmission of HEV by plasmapheresis Vincent Mallet, MD, PhD CHU Cochin, Université Paris Descartes, APHP, Inserm Transmission of HEV by secured plasma Transmission of HEV by plasma IA Transmission of
More informationPegasys Pegintron Ribavirin
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.47 Subsection: Anti-infective nts Original Policy Date: January 1, 2019 Subject: Pegasys Pegintron
More informationSEE EDITORIAL ON PAGE 436 PATIENTS AND METHODS
Interferon Beta Prevents Recurrence of Hepatocellular Carcinoma After Complete Resection or Ablation of the Primary Tumor A Prospective Randomized Study of Hepatitis C Virus Related Liver Cancer KENJI
More informationResearch Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection
International Hepatology, Article ID 358206, 5 pages http://dx.doi.org/10.1155/2014/358206 Research Article Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic
More informationPeginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
ORIGINAL ARTICLE July-August, Vol. 13 No. 4, 2014: 350-355 Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection Ching-Chung Lin,*,, Chia-Hsien Wu, Huan-Lin Chen,
More informationViral hepatitis and Hepatocellular Carcinoma
Viral hepatitis and Hepatocellular Carcinoma Hashem B. El-Serag, MD, MPH Dan L. Duncan Professor of Medicine Chief, Gastroenterology and Hepatology Houston VA & Baylor College of Medicine Houston, TX Outline
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationHepatitis C in Disclosures
Hepatitis C in 2018 Sandeep Mukherjee, MD CHI Health and Creighton University Medical Center Division of Gastroenterology Grant support: Abbvie Disclosures Speaker: Abbvie, Gilead, Merck Section editor
More informationKENJI IKEDA, 1 SATOSHI SAITOH, 1 YASUJI ARASE, 1 KAZUAKI CHAYAMA, 1 YOSHIYUKI SUZUKI, 1 MASAHIRO KOBAYASHI, 1 AKIHITO TSUBOTA, 1
Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long-Term Observation Study of 1,643 Patients Using Statistical Bias Correction With Proportional
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1997, by the Massachusetts Medical Society VOLUME 336 M ARCH 13, 1997 NUMBER 11 ACUTE NON-A E HEPATITIS IN THE UNITED STATES AND THE ROLE OF HEPATITIS G VIRUS
More informationHepatitis C wi w t i h Ju J dy y W y W a y t a t t
Hepatitis C with Judy Wyatt Hepatitis C and the histopathologist Pre-2006 biopsy based treatment of moderate-severe chronic hepatitis Now biopsy for: Watchful waiting, to confirm mild disease? Cirrhosis
More informationPrevalence of Torque Teno Virus in Hepatitis C Virus Infected Patients
J. Appl. Environ. Biol. Sci., 4(6)20-25, 2014 2014, TextRoad Publication ISSN: 2090-4274 Journal of Applied Environmental and Biological Sciences www.textroad.com Prevalence of Torque Teno Virus in Hepatitis
More informationThe Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients
Gut and Liver, Published online August 14, 2017 ORiginal Article The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients Shinya Taki 1, Hideyuki Tamai 1, Yoshiyuki Ida 1,
More information